16th Meeting Home > Meeting > 16th Meeting
Agenda of the 16th ANOLD Meeting
Date|  Sunday , March 27th, 2016
Time|  12:30 -13:30
Venue |  Asan Medical Center, Seoul, Korea
Participants
Arvind Bhome, MD
Indian Coalition for the Study of Obstructive Lung Diseases, Pune, India
Sang-Do Lee, MD, Yeon-Mok Oh, MD, Jae Seung Lee, MD, Bo Young Lee, Dong Kyu Oh
University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Woo Jin Kim, MD
Kangwon National University Hospital, Chuncheon, Korea
Vitull K. Gupta, MD, Sonia Arora, Meghna Gupta
Kishori Ram Hospital and Diabetes Care Centre, Bathinda, India
Richard Loh, MD, Choo Khoon Ong, MD
Penang Medical College, Penang, Malaysia
Jeng-Shing Wang, MD
Yuan’s General Hospital, Kaohsiung, Taiwan
Le Thi Tuyet Lan, MD
University Hospital Hochiminh City, Vietnam
Agenda
1.Identification of Subgroups of COPD in 14 Asian Cities
2. Discussion Agenda – LABA and LABA+LAMA in COPD as an ICS sparer
3. Recruitment Status of ANOLD Study I & I
4. Current Status of CT and DNA data
5. Patients’ Characteristics of ANOLD Study I & II
6. Characteristics of ANOLD II COPD Patients in Each Country
7. Current Status of ANOLD 2nd STAGE Follow-up Schedule
8. Grading Criteria of ANOLD 2nd stage e-CRF
Follow-up analysis of the three clusters in ANOLD 1 & 2 patients
WJ Kim presented a follow-up analysis on the patients of the three clustering group. Among the three groups of cluster, the cluster with worse lung function and more symptoms showed rapid worsening in SGRQ score and more exacerbation during the follow-up
Follow-up data
Follow-up data are essential in the 2nd ANOLD paper. More follow-up of the patients should be encouraged.
GOLD A, B, C, D classification
More analysis of the GOLD A, B, C, D classification was suggested for the three clusters. The analysis would reveal the characteristics of the three clusters.
Analysis of inhaler use
Pf. Lan thankfully proposed an additional analysis of ICS use for the patients of ANOLD COPD cohort, especially GOLD B patients. For the analysis of ICS use, ACOS and eosinophilia may be considered as well. LABA alone or the combination of LABA and LAMA should also be analyzed.
Next Meeting (17th ANOLD Meeting)
during APSR 2016, November 12-15, 2016, Bangkok, Thailand
ANOLD Coordination Center
Asan Medical Center, #88, Olympic-ro, 43-gil, Songpa-gu, Seoul (Zip 138-736), South Korea
Tel:+82-2-3010-7269, Fax: +82-2-3010-4650     
Copyright (C) 2018 ANOLD.
MEGIC eCRF v1.0
MEDICALLOGIC